These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6639823)

  • 1. Side effects of amrinone therapy.
    LeJemtel TH
    Br Heart J; 1983 Nov; 50(5):499-500. PubMed ID: 6639823
    [No Abstract]   [Full Text] [Related]  

  • 2. Dual effects of amrinone and caffeine on cardiac contractility: positive versus negative inotropy.
    Malécot CO; Katzung BG
    Proc West Pharmacol Soc; 1984; 27():11-3. PubMed ID: 6494142
    [No Abstract]   [Full Text] [Related]  

  • 3. Developmental changes in the interactions of amrinone and ouabain in canine ventricular muscle.
    Binah O; Rosen MR
    Dev Pharmacol Ther; 1983; 6(5):333-46. PubMed ID: 6628165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amrinone, a new cardiotonic agent].
    Taira N
    Nihon Rinsho; 1983 Dec; 41(12):2691-7. PubMed ID: 6371299
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine.
    Takeda K; Matsui K; Nakazawa M; Nakahara H; Imai H; Imai S
    Jpn J Pharmacol; 1986 Mar; 40(3):381-8. PubMed ID: 3012165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inotropic and vasodilator effects of amrinone on isolated human tissue.
    Wilmshurst PT; Walker JM; Fry CH; Mounsey JP; Twort CH; Williams BT; Davies MJ; Webb-Peploe MM
    Cardiovasc Res; 1984 May; 18(5):302-9. PubMed ID: 6733734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac effects of Cordemcura in vitro].
    Hagen A; Sonnenburg F; Frömmel B; Fischer R; Hennig R; Just E; Landmann H; Göres E
    Pharmazie; 1986 Mar; 41(3):186-9. PubMed ID: 3714791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The improvement of cardiac performance by amrinone, a new cardiotonic drug, in an experimental failing heart preparation of the dog.
    Satoh K; Maruyama M; Taira N
    Jpn Heart J; 1982 Nov; 23(6):975-80. PubMed ID: 7161881
    [No Abstract]   [Full Text] [Related]  

  • 9. Positive inotropic action of amrinone: effect of elevated external Ca2+.
    Rendig SV; Amsterdam EA
    J Cardiovasc Pharmacol; 1984; 6(2):293-9. PubMed ID: 6200719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inotropic effects of amrinone and milrinone on contraction and relaxation of isolated cardiac muscle.
    Sys SU; Goenen MJ; Chalant CH; Brutsaert DL
    Circulation; 1986 Mar; 73(3 Pt 2):III25-35. PubMed ID: 3002662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
    Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M
    Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amrinone, a cardiotonic drug, on calcium movements in dog erythrocytes.
    Parker JC; Harper JR
    J Clin Invest; 1980 Aug; 66(2):254-9. PubMed ID: 7400314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of a new positive inotropic agent on heart failure of a cardiopulmonary preparation].
    Kabela E; Michaels DC; Felice EL
    Arch Inst Cardiol Mex; 1979; 49(5):892-907. PubMed ID: 398199
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the electrocardiographic effects of equipotent inotropic doses of amrinone and ouabain in isolated hearts of guinea pigs].
    Furlan CC; Tucci PJ
    Arq Bras Cardiol; 1985 Jul; 45(1):1-5. PubMed ID: 3833121
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on "cardiotonic activity of amrinone-win 40680 [5-amino-3-4'-bypyridin-6(1H)-one]".
    Katz AM; McCall D; Messineo FC; Pappano A; Dobbs W
    Circ Res; 1980 Jun; 46(6):887-8. PubMed ID: 7379253
    [No Abstract]   [Full Text] [Related]  

  • 16. Reduction of lethal toxicity of doxorubicin by amrinone.
    Bossa R; Galatulas I; Savi G; Supino R; Zunino F
    Tumori; 1982 Dec; 68(6):499-504. PubMed ID: 7168015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
    Hayes JS; Bowling N; Boder GB; Kauffman R
    J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct vasodilator and positive inotropic actions of amrinone.
    Millard RW; Dubé G; Grupp G; Grupp I; Alousi A; Schwartz A
    J Mol Cell Cardiol; 1980 Jun; 12(6):647-52. PubMed ID: 7452740
    [No Abstract]   [Full Text] [Related]  

  • 19. Amrinone relaxes potassium-induced contracture of failing right ventricular muscle of cats.
    Gaide MS; Fitterman WS; Wiggins JR; Myerburg RJ; Cameron JS; Bassett AL
    J Cardiovasc Pharmacol; 1983; 5(2):335-40. PubMed ID: 6188912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electromechanical dissociation and possible uncoupling of phosphorylation following tachydysrhythmogenic dose of amrinone in the guinea-pig Langendorff heart preparation.
    Onuaguluchi G; Tanz RD
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):81-97. PubMed ID: 6497512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.